Identification of nras diagnostic biomarkers and drug targets for endometrial cancer—an integrated in silico approach

HIGHLIGHTS

• who: Larsen Alessandro and colleagues from the Department of Biotechnology, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia have published the article: Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Canceru2014An Integrated in Silico Approach, in the Journal: (JOURNAL) of 19/08/2022
• what: The analysis showed a hazard ratio (HR)=0 and logrank p-value=0.028 for EC cancer . Post-translational modifications analysis was carried out to determine modification of the side chain of amino_acids of proteins, which may affect protein structure and functions and disrupt biological processes . The analysis . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.